Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Balázs Győrffy"'
Autor:
Verónica Corrales-Sánchez, Gabriel Santpere, Atanasio Pandiella, Ana Alcaraz-Sanabria, Balázs Győrffy, Alberto Ocaña
Publikováno v:
Oncotarget
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
In breast cancer, it is unclear the functional modifications at a transcriptomic level that are associated with the evolution from epithelial cells and ductal carcinoma in situ (DCIS) to basal-like tumors. By applying weighted gene co-expression netw
Autor:
Jan Budczies, Otília Menyhárt, Gyöngyi Munkácsy, Francisco J. Esteva, Teresa Puig Miquel, Balázs Győrffy, András Szabó
Publikováno v:
Oncotarget
// Otilia Menyhart 1 , Jan Budczies 2 , Gyongyi Munkacsy 1 , Francisco J. Esteva 3 , Andras Szabo 1 , Teresa Puig Miquel 4 and Balazs Győrffy 1, 5 1 Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary 2 Institute of Pathology, Char
Autor:
Yong Han, Jie Ma, Zhong-Sheng Zhao, Wei Wang, Xi Chen, Mei-Hua Ye, Balázs Győrffy, Guo-Qing Ru, Hui-Ju Wang, Wen-Juan Xu, Dong-Sheng Huang, Yuan Chen, Xiang-Lei He
Publikováno v:
Oncotarget
This study aims to investigate the prognostic power of carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) in gastric cancer (GC) and its potential role in cancer development and progression. Data mining results show that CEACAM6 is o
Publikováno v:
Oncotarget
// Huiyu Xu 1, * , Yong Han 2, * , Jiaying Lou 3 , Hongxian Zhang 4 , Yue Zhao 1 , Balazs Győrffy 5, 6 and Rong Li 1 1 Department of Obstetrics and Gynecology, Reproductive Medical Center, Peking University Third Hospital, Beijing, P.R. China 2 Depa
Autor:
Alexander A. Chumanevich, Hippokratis Kiaris, Igor B. Roninson, Eugenia V. Broude, Mengqian Chen, David Oliver, Jiaxin Liang, Serena Altilia, Martina McDermott, James M. Rae, Balázs Győrffy, Michael Shtutman, Chang-uk Lim
Publikováno v:
Oncotarget
// Martina S.J. McDermott 1 , Alexander A. Chumanevich 1 , Chang-uk Lim 1 , Jiaxin Liang 1 , Mengqian Chen 1 , Serena Altilia 1 , David Oliver 1 , James M. Rae 2 , Michael Shtutman 1 , Hippokratis Kiaris 1 , Balazs Győrffy 3 , Igor B. Roninson 1 and
Autor:
Nuh N. Rahbari, Christoph Kahlert, Sebastian Schölch, Christoph Reißfelder, Vittorio Branchi, Ulrich Bork, Jürgen Weitz, Balázs Győrffy, Alexander M. Betzler, Lahiri Kanth Nanduri, Praveen Radhakrishnan, Sebastián A. García, Anka Swiersy
Publikováno v:
Oncotarget
// Sebastian A. Garcia 1, 2 , Anka Swiersy 1 , Praveen Radhakrishnan 2 , Vittorio Branchi 3 , Lahiri Kanth Nanduri 1 , Balazs Győrffy 4, 5 , Alexander M. Betzler 1 , Ulrich Bork 1, 2 , Christoph Kahlert 1, 2 , Christoph Reisfelder 1, 2 , Nuh N. Rahb
Autor:
Laszlo Tretter, András Szabó, Balázs Győrffy, Attila Ambrus, Lőrinc S. Pongor, Hajnalka Harami-Papp, Peter Hauser, Ádám Nagy, Gyöngyi Munkácsy, Gergő Horváth
Publikováno v:
Oncotarget
// Hajnalka Harami-Papp 1, * , Lőrinc S. Pongor 1, 3, * , Gyongyi Munkacsy 1 , Gergő Horvath 2 , Adam M. Nagy 2 , Attila Ambrus 2 , Peter Hauser 3 , Andras Szabo 3 , Laszlo Tretter 2 , Balazs Győrffy 1 1 MTA TTK Lendulet Cancer Biomarker Research
Publikováno v:
Oncotarget
Overexpression of lysyl oxidase (LOX) is often observed in estrogen receptor negative (ER-) breast cancer patients with bone metastasis. In the present bioinformatics study, we observed that LOX is a prognostic factor for poor progression free surviv
Publikováno v:
Oncotarget
Hypoxic environment is critical in colorectal cancer (CRC) development. Most studies have mainly focused on hypoxia-inducible factor (HIF)-1α and HIF-2α as the major hypoxic transcription factors in CRC development and progression. However, the rol
Autor:
Sabrina, Noack, Monika, Raab, Yves, Matthess, Mourad, Sanhaji, Andrea, Krämer, Balázs, Győrffy, Lars, Kaderali, Ahmed, El-Balat, Sven, Becker, Klaus, Strebhardt
Publikováno v:
Oncotarget
The taxanes are effective microtubule-stabilizing chemotherapy drugs that inhibit mitosis, induce apoptosis, and produce regression in a fraction of cancers that arise at many sites including the ovary. Novel therapeutic targets that augment taxane e